Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00036062 · ClinicalTrials.gov registry record · Phase 1

A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury

A Phase 1 study of Acute Lung Injury and Respiratory Distress Syndrome, Adult, sponsored by Eli Lilly and Company.

Completed
Registry status
Phase 1
Development phase
600
Enrollment target
20
Study locations

NCT00036062 is a Phase 1 study of Acute Lung Injury and Respiratory Distress Syndrome, Adult that has completed, run by Eli Lilly and Company. The registered enrollment target is 600 participants, above the 66-participant average among 10 other Acute Lung Injury trials with a reported enrollment target (809% higher). The trial reports 20 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00036062, a Phase 1 study of Acute Lung Injury and Respiratory Distress Syndrome, Adult, has completed, sponsored by Eli Lilly and Company.

COMPLETED
Registry status
Phase 1
Development phase
600 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to determine whether sivelestat will reduce the amount of time a patient must spend on a ventilator and/or increase the chance of survival of patients with acute lung injury.

Conditions Studied

Acute Lung Injury Respiratory Distress Syndrome, Adult

Interventions

  • DRUG Sivelestat

Study Locations (20)

Illinois

  • - Chicago
  • - Elk Grove Village
  • - Maywood
  • - North Chicago

California

  • - Orange
  • - Sacramento
  • - San Diego

Florida

  • - Bay Pines
  • - Clearwater
  • - Fort Lauderdale

Arizona

  • - Phoenix
  • - Tucson

Colorado

  • - Denver
  • - Englewood

Georgia

  • - Augusta
  • - Austell

Alabama

  • - Birmingham

Connecticut

  • - New Haven

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2001-08
Est. Completion 2002-12
Phase Phase 1

Sponsor

Eli Lilly and Company

1,341 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00036062

The ClinicalTrials.gov registry entry for NCT00036062 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 66-participant average among 10 other Acute Lung Injury trials with a reported enrollment target (809% higher). The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Acute Lung Injury appearing as the primary indexed condition, and to 1 intervention - of which Sivelestat is the first listed.

NCT00036062 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Illinois, California, Florida.

Frequently Asked Questions

What is clinical trial NCT00036062 about?

NCT00036062 is a clinical study titled "A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury". The purpose of this study is to determine whether sivelestat will reduce the amount of time a patient must spend on a ventilator and/or increase the chance of survival of patients with acute lung injury.

What is the current status of trial NCT00036062?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 600 participants. The study started on 2001-08. Estimated completion is 2002-12.

What conditions does trial NCT00036062 study?

This clinical trial studies the following conditions: Acute Lung Injury, Respiratory Distress Syndrome, Adult.

What interventions are being tested in trial NCT00036062?

The interventions under investigation include: Sivelestat (DRUG).

Who is sponsoring clinical trial NCT00036062?

This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00036062 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acute Lung Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Acute Lung Injury

All registered trials for this condition

Respiratory Distress Syndrome, Adult

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.